1. Japan Stocks

  2. •

    Healthcare

  3. •

    Medical - Devices
Fukuda Denshi Co., Ltd.

Fukuda Denshi Co., Ltd.

6960.T
Fukuda Denshi Co., Ltd.JP flagTokyo Stock Exchange
11,510.00
JPY
-30.00
- -
310.95BMarket Cap
Fukuda Denshi Co., Ltd.
6960.T
(Tokyo Stock Exchange)

Recent

price

11,510.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
2,348.33
2,507.62
2,739.34
3,093.9
3,677.74
3,894.01
4,021.06
3,991.97
4,234.84
4,264.15
4,394
4,853.36
4,367.89
4,451.49
4,672.48
4,822.17
2,559.61
Revenue per Share
93.19
114.33
155.91
207.74
258.43
256.04
252.74
287.76
306.24
314.68
316.52
486.67
536.19
571.21
622.44
645.41
308.16
Basic EPS, GAAP
174.34
227.68
82.16
133.64
196.65
210.73
149.66
247.79
340.77
183.87
236.54
327.1
289.42
350.37
326.02
698.24
- -
Free Cash Flow per Basic Share
40.17
41.08
40.59
48.16
66.5
75.17
71.86
75.12
82.8
87.8
90.65
90.52
150.91
173.67
182.87
191.45
- -
Dividend per Share
1,819.45
1,972.41
2,214.89
2,564.55
2,919.01
3,272.55
3,297
3,363.86
3,594.3
3,820.83
4,056.2
4,468.28
4,852.56
5,249.2
5,726.59
6,419.79
6,127.67
Book Value per Share
1,963.58
2,054.54
2,263.97
2,561.37
2,663.59
3,108.87
3,337.16
3,399.73
3,655.12
3,863.51
4,041.64
4,510.78
4,904.21
5,336.91
5,565.53
6,239.85
5,904.6
Tangible Book Value per Share
38
36
34
31
29
28
29
30
30
30
30
30
30
30
30
29
29
Basic Weighted Avg Shares
88,147
90,169
92,524
96,239
107,574
108,269
117,222
121,747
128,883
129,775
133,393
146,756
132,098
134,648
140,323
139,007
73,782
Sales/Revenue/Turnover
7.94
8.9
9.93
10.64
10.98
9.52
9.09
9.91
9.57
9.74
9.96
13.5
17.19
17.89
18.89
18.61
17.01
Operating Margin (%)
5,813
5,978
5,963
5,539
5,636
6,161
6,586
7,070
7,459
7,856
8,012
8,360
9,016
9,368
9,725
10,549
- -
Depreciation Expense
3,498
4,111
5,266
6,462
7,559
7,119
7,368
8,776
9,320
9,577
9,609
14,716
16,216
17,278
18,693
18,605
8,883
Net Income, GAAP
45.93
46.46
43.75
41.37
39.82
40.65
34.69
27.3
30
27.49
32.1
30.02
31.65
31.44
30.73
31.41
30.1
Effective Tax Rate (%)
3.97
4.56
5.69
6.71
7.03
6.58
6.29
7.21
7.23
7.38
7.2
10.03
12.28
12.83
13.32
13.38
12.04
Profit Margin (%)
43,090
39,137
39,292
36,986
36,539
39,739
51,605
56,982
61,105
63,958
63,843
71,565
80,907
89,211
84,705
91,920
86,081
Working Capital
214
751
857
1,261
1,340
384
420
953
838
2,043
2,040
2,004
1,805
1,624
1,474
1,288
- -
LT Debt
76,049
75,623
77,846
82,082
81,736
88,990
99,830
105,973
113,251
119,183
124,427
137,981
149,856
163,047
169,005
181,651
171,973
Total Equity
4.75
5.37
6.38
7.08
8.07
6.74
7.05
8.19
7.54
7.54
7.07
9.98
10.21
10.07
10.58
9.71
4.97
Return on Invested Capital (%)
5.02
5.74
7.01
8.08
8.83
7.84
7.7
8.62
8.58
8.26
7.78
11.07
11.21
11.06
11.08
10.25
5.15
Return on Capital (%)
5.2
5.91
7.23
8.36
9.15
8.07
7.88
8.83
8.79
8.49
8.03
11.4
11.51
11.31
11.3
10.42
5.19
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Mar'24
Jun'25
Sep'25
ST Debt
2,037
- -
1,800
LT Borrowings
- -
- -
- -
LT Finance Leases
1,474
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
29
- -
29
Market Capitalization
207,285
193,818
221,956

Working Capital

FRC

•

in mil. unless spec.
Mar'24
Jun'25
Sep'25
Total Current Assets
119,136
- -
113,394
Cash, Cash Equivalents & STI
60,222
- -
64,198
Accounts Receivable, Net
36,770
- -
27,852
Inventories
15,656
- -
15,442
Total Current Liabilities
34,431
- -
27,313
Payables & Accruals
- -
- -
- -
ST Debt
2,037
- -
1,800
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
7.43%
7.89%
7.48%
Free Cash Flow
21.25%
29.06%
105.58%
Net Income, GAAP
10.95%
15.52%
-0.47%
Sales/Revenue/Turnover
2.67%
1.05%
-0.94%
Total Cash Common Dividend
11.5%
17.27%
0.49%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
29,180
37,361
32,717
41,065
140,323
2025
- -
- -
- -
- -
139,007
2026
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
115.54
- -
- -
- -
622.44
2025
- -
- -
- -
- -
645.41
2026
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
182.87
2025
- -
- -
- -
- -
191.45
2026
- -
- -
- -
- -
- -
Similar Companies
Stryker Corporation (SYK)
TaiDoc Technology Corporation (4736.TWO)
Stryker Corporation (0R2S.L)
Jafron Biomedical Co.,Ltd. (300529.SZ)
Implantica AG (IMP-A-SDB.ST)
Coloplast A/S (CBHD.DE)
Business
Fukuda Denshi Co., Ltd. (6960.T) manufactures and sells medical electronic equipment. The company offers patient monitors including the BSM-6000 series and BSM-3500 series; electrocardiographs such as the FC-9800 and FC-3200; ultrasound systems like the SonoScape E series; defibrillators including the FP-8000; electroencephalographs; evoked potential/EMG/EP systems; telemedicine equipment; and sleep diagnostic systems, among other diagnostic and therapeutic devices. Fukuda Denshi serves hospitals, clinics, and healthcare facilities primarily in Japan, with international operations in Asia, Europe, and the Americas. Founded in 1951 and headquartered in Tokyo, Japan, the company operates through segments including biomedical measurement systems and others, with subsidiaries such as Fukuda Denshi USA, Inc. and European branches supporting global distribution. In recent developments, Fukuda Denshi expanded its product portfolio with the launch of advanced AI-integrated patient monitoring solutions in 2024, enhancing real-time diagnostics. The company formed a strategic partnership with a leading telemedicine provider in Asia in early 2025 to integrate its ECG and ultrasound technologies into remote healthcare platforms. Additionally, Fukuda Denshi acquired a minority stake in a Japanese AI health tech startup in late 2024 to bolster its digital health offerings amid growing demand for connected medical devices.